Jazz Pharmaceuticals to Buy Celator for about $1.5 Bln
May 31, 2016 at 06:48 AM EDT
Jazz Pharmaceuticals PLC agreed to buy Celator Pharmaceuticals Inc. in a roughly $1.5 billion deal that represents a huge premium for a company with a promising leukemia drug but no revenue.
